Rishabh Chawla joined V-Bio Ventures as a Junior Analyst in 2018.
Rishabh brings 6 years of experience in conducting translational research and has life science VC and banking experience. Prior to joining V-Bio Ventures, Rishabh interned at INKEF Capital, VI-partners and Kempen & co. Prior to this he worked as a scientist at the University hospital Tübingen, Germany, where he was involved in identifying novel drug targets for therapy resistant cancers and liver regeneration.
Rishabh holds a PhD in Biochemistry from the Eberhard Karls University of Tübingen, Germany, MRes in Molecular Medicine from the University of Glasgow, UK, and B.Tech (Engineering) in Industrial Biotechnology from VIT-University, India
“Good science must be followed by great implementation”